# Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

> **NCT01109979** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 24 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Estradiol+MPA
- **DRUG:** Estradiol+Drospirenone

## Key facts

- **NCT ID:** NCT01109979
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-01
- **Final completion:** 2016-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109979, "Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01109979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*